Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19
2021年6月29日 更新者:Buket AKINCI、Biruni University
The effects of COVID-19 on body systems and functions are still being investigated.
ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health.
The aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.
研究概览
地位
完全的
详细说明
The effects of COVID-19 on body systems and functions are still being investigated.
ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health.
It has been examined that menstruation volume decreased or cycle lengthened in one-fifth of women who had COVID-19, and this condition was more intense in those who had severe COVID-19.
Studies have shown that the possible effects of COVID-19 on the female genital system often remain theoretical hypotheses.
In the literature, there was no study in which menstrual dysfunctions and secondary problems caused by the state of inactivity entering our lives during pandemic were discussed in a wide spectrum of women who had COVID-19.
Therefore the aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.
研究类型
观察性的
注册 (实际的)
180
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Istanbul、火鸡
- Biruni University
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 45年 (成人)
接受健康志愿者
不适用
有资格学习的性别
女性
取样方法
概率样本
研究人群
The study will include 200 volunteers, female individuals aged 18-45 who have had COVID-19.
描述
Inclusion Criteria:
- Being between the ages of 18 and 45,
- PCR test result positive confirmed having COVID-19 infection,
- Women had at least one period of Menstrual cycle after COVID-19
- Being an Internet connection,
- To be able to speak and write in Turkish.
Exclusion Criteria:
- To be in the premenaposual/postmenopausal period (to be in the transition period to menopause or in the period after menopause.)
- Having insufficient co-operation.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Menstrual Symptom Questionnaire
大体时间:1 day
|
This scale was developed to assess menstrual pain and symptoms.
It is a five-point Likert-type scale consisting of 24 items.
Participants will be asked to give a number between 1 (never) and 5 (always) to their menstrual symptoms.
Total score will be calculated by taking the total score of the items in the scale.
Increasing the average score indicates that the severity of menstrual symptoms increased.
|
1 day
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Fatigue Severity Scale
大体时间:1 day
|
Each question in this scale consisting of Likert type questions: (1) I strongly disagree (2) I do not attend (3) I tend not to participate (4) I am indecisive (5) I tend to join (6) I participate (7) It is scored as I strongly agree.
A score of 4 or higher on the questions indicates severe fatigue.
The scoring of the scale, which consists of 9 questions in total, varies between 9 and 63, while a total score of 36 and above indicates fatigue.
|
1 day
|
|
Short Form Of Coronavirus Anxiety Scale
大体时间:1 day
|
The questionnaire has a five-point Likert type rating and consists of 5 items.
"0: none", "1: rarely, less than a day or two", "2: a few days", "3: more than 7 days," They will be asked to rank the options "," 4: almost every day during the last two weeks "according to the five elements of the scale.
|
1 day
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 研究主任:Buket Akinci、Biruni University
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2021年5月18日
初级完成 (实际的)
2021年5月30日
研究完成 (实际的)
2021年6月1日
研究注册日期
首次提交
2021年3月17日
首先提交符合 QC 标准的
2021年3月18日
首次发布 (实际的)
2021年3月19日
研究记录更新
最后更新发布 (实际的)
2021年6月30日
上次提交的符合 QC 标准的更新
2021年6月29日
最后验证
2021年6月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.